Skip to main content

Table 2 Comparison of clinical data [n(%)]

From: Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

  Research group (n=142) Control group (n=120) t or χ2 P
Age (year) 36.29±5.33 35.12±4.62 1.881 0.061
Sex    0.728 0.393
 Male 89 (62.68) 69 (57.50)   
 Female 53 (37.32) 51 (42.50)   
Tumor grade     
 Grade I to II 79 (55.63)    
 Grade III to IV 63 (44.37)    
Tumor diameter (cm) 4.51±1.27    
Tumor location     
 Frontal lobe 41 (28.87)    
 Temporal lobe 58 (40.85)    
 Parietal lobe 30 (21.13)    
 Others 13 (9.15)    
Distant metastasis     
 Yes 39 (27.46)    
 No 103 (72.54)    
Family history of glioma    3.133 0.077
 Yes 19 (13.38) 5 (4.17)   
 No 123 (86.62) 115 (93.33)   
Smoking    0.257 0.612
 Yes 54 (38.03) 42 (35.00)   
 No 88 (61.97) 78 (65.00)   
Drinking    0.541 0.462
 Yes 62 (43.66) 47 (39.17)   
 No 80 (56.34) 73 (60.83)